Shorepoint Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AutoZone
AZO
|
+$8.28M |
| 2 |
Mastercard
MA
|
+$6.55M |
| 3 |
Microsoft
MSFT
|
+$6.4M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$5.67M |
| 5 |
Broadcom
AVGO
|
+$5.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$2.72M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$719K |
| 3 |
AES
AES
|
+$353K |
| 4 |
CVS Health
CVS
|
+$338K |
| 5 |
Kraft Heinz
KHC
|
+$254K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.1% |
| 2 | Technology | 14.95% |
| 3 | Financials | 12.02% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Industrials | 6.93% |
Similar funds
Shorepoint Capital Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Shorepoint Capital Partners held 140 positions worth $360M, up 72% from $210M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Shorepoint Capital Partners deployed $130M of net new capital in Q4 2022, opening 66 new positions and adding to 49 existing holdings. Its largest new stake was AutoZone: 3,424 shares worth $8.44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Schwab US Dividend Equity ETF, an estimated $719K trimmed.
- Shorepoint Capital Partners's largest Q4 2022 buy was AutoZone: 3,424 shares worth $8.44M.
- Shorepoint Capital Partners added most to Microsoft in Q4 2022, an estimated $6.4M increase.
- Shorepoint Capital Partners's biggest Q4 2022 reduction was Schwab US Dividend Equity ETF, cutting an estimated $719K.
- Shorepoint Capital Partners fully exited Dominion Energy in Q4 2022, selling an estimated $2.72M.
- Shorepoint Capital Partners's ten largest holdings make up 26% of its $360M portfolio in Q4 2022.
- Shorepoint Capital Partners opened 66 new positions and closed 2 in Q4 2022.
- Shorepoint Capital Partners's portfolio value rose 72% quarter-over-quarter to $360M.
Based on Shorepoint Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.